SJM
19
5
NUE
51
3
OMC
62
3
MS
69
3
ISRG
71
2
WMB
63
3
NRG
67
8
NWS
62
4
GE
61
4
OKE
68
4
EBAY
43
3
ROP
53
2
MCD
54
4
BF.B
31
2
AIV
51
4
USB
46
3
CMS
57
3
DUK
37
2
HAS
37
4
CTAS
53
3
SJM
19
5
NUE
51
3
OMC
62
3
MS
69
3
ISRG
71
2
WMB
63
3
NRG
67
8
NWS
62
4
GE
61
4
OKE
68
4
EBAY
43
3
ROP
53
2
MCD
54
4
BF.B
31
2
AIV
51
4
USB
46
3
CMS
57
3
DUK
37
2
HAS
37
4
CTAS
53
3
Financhill
Back

OncoCyte Vs. ProPhase Labs Industry Stock Comparison

Sell
43

OCX
OncoCyte

Last Price:
2.79
Seasonality Move:
66.51%
Sell
36

PRPH
ProPhase Labs

Last Price:
2.04
Seasonality Move:
22.84%
Sell
43
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.92. The Score for OCX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $2.08. The Score for PRPH is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight buying pressure.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $2.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 40.64 Sell
Chaikin Money Flow: 5897 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.97 - 3.11) Sell
Bollinger Bands (100): (2.9 - 3.2) Sell

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 37.59 Sell
Chaikin Money Flow: -20388 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.23 - 2.43) Sell
Bollinger Bands (100): (2.2 - 3.54) Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.01 Sell
20-day SMA: 3.06 Sell
50-day SMA: 3.06 Sell
200-day SMA: 2.96 Sell
8-day EMA: 2.99 Sell
20-day EMA: 3.03 Sell
50-day EMA: 3.04 Sell
200-day EMA: 3.26 Sell

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.26 Sell
20-day SMA: 2.32 Sell
50-day SMA: 2.41 Sell
200-day SMA: 4.07 Sell
8-day EMA: 2.23 Sell
20-day EMA: 2.3 Sell
50-day EMA: 2.48 Sell
200-day EMA: 3.74 Sell

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.32 per share.

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):